Business
Press Release Dec 03 2021
Morepen Laboratories Limited has informed the Exchange regarding a press release dated December 03, 2021, titled "Morepen gets US FDA Approval for Fexofinadine (Allegra) Expected to start export in Q4 FY22".
About this update from Morepen Laboratories Limited
[{"type":"text","content":" Morepen Laboratories Limited has informed the Exchange regarding a press release dated December 03, 2021, titled \"Morepen gets US FDA Approval for Fexofinadine (Allegra) Expected to start export in Q4 FY22\". View Attachment","length":362,"tagName":"div"}]